Atlas Trials

Compare the Efficacy and Safety of Dec-FB4 and FB4 as Conditioning Regimen for AML-MR

Clinical trial NCT06297772 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06297772
Sponsor
Ruijin Hospital
Status
NOT_YET_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
AML, Adult
Start date
2024-06-01
Primary completion
2026-03-01
Enrollment
220

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.